Intellia Thera CS (NTLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 193,389 | 156,172 | 126,880 | 189,182 | 120,495 |
| Marketable Securities | 317,655 | 303,479 | 376,867 | 412,333 | 537,619 |
| Receivables | 11,050 | 11,353 | 10,504 | 8,517 | 8,854 |
| TOTAL | $581,941 | $495,945 | $551,392 | $639,863 | $710,902 |
| Non-Current Assets | |||||
| PPE Net | 20,421 | 22,806 | 25,123 | 27,381 | 28,763 |
| Investments And Advances | 158,814 | 170,855 | 203,353 | 260,215 | 286,567 |
| Other Non-Current Assets | 164,099 | 209,288 | 206,295 | 263,556 | 147,119 |
| TOTAL | $343,334 | $402,949 | $434,771 | $551,152 | $462,449 |
| Total Assets | $925,275 | $898,894 | $986,163 | $1,191,015 | $1,173,351 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 13,260 | 9,802 | 12,364 | 14,589 | 13,145 |
| Accrued Expenses | 40,841 | 41,553 | 40,805 | 55,355 | 51,206 |
| TOTAL | $93,726 | $95,499 | $112,593 | $110,851 | $105,683 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 12,247 | 17,154 | 20,661 | 20,661 | 22,155 |
| Other Non-Current Liabilities | 70,588 | 75,601 | 80,490 | 189,952 | 82,446 |
| TOTAL | $83,127 | $88,140 | $93,651 | $208,208 | $105,053 |
| Total Liabilities | $176,853 | $183,639 | $206,244 | $319,059 | $210,736 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 115,830 | 107,347 | 103,583 | 103,518 | 101,849 |
| Common Shares | 12 | 10 | 10 | 10 | 10 |
| Retained earnings | -2,494,308 | -2,392,984 | -2,291,729 | -2,177,400 | -2,048,502 |
| Other shareholders' equity | 990 | 653 | 1,057 | 605 | 3,297 |
| TOTAL | $748,422 | $715,255 | $779,919 | $871,956 | $962,615 |
| Total Liabilities And Equity | $925,275 | $898,894 | $986,163 | $1,191,015 | $1,173,351 |